Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors

[1]  Masato Yamamoto,et al.  Infectivity-Enhanced Cyclooxygenase-2-Based Conditionally Replicative Adenoviruses for Esophageal Adenocarcinoma Treatment , 2004, Cancer Research.

[2]  D. Curiel,et al.  Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. , 2004, Virology.

[3]  D. Curiel,et al.  A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma , 2004, Gene Therapy.

[4]  B. Liu,et al.  Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  M. Rots,et al.  A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism. , 2003, Virology.

[6]  D. Nettelbeck,et al.  Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism , 2003, Cancer biology & therapy.

[7]  D. Curiel,et al.  Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. , 2003, Cancer research.

[8]  M. Rots,et al.  Generation of an adenoviral vector containing an addition of a heterologous ligand to the serotype 3 fiber knob , 2003, Cancer Gene Therapy.

[9]  D. Curiel,et al.  Modulation of Adenovirus Vector Tropism via Incorporation of Polypeptide Ligands into the Fiber Protein , 2002, Journal of Virology.

[10]  D. Curiel,et al.  Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency. , 2002, Human gene therapy.

[11]  D. Curiel,et al.  Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  J. Jakubczak,et al.  Enhanced Gene Transfer to Rabbit Jugular Veins by an Adenovirus Containing a Cyclic RGD Motif in the HI Loop of the Fiber Knob , 2001, Journal of Vascular Research.

[13]  C. Balagué,et al.  Replicative adenoviruses for cancer therapy , 2000, Nature Biotechnology.

[14]  D. Curiel,et al.  An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches. , 1999, Gynecologic oncology.

[15]  C. Miller,et al.  A system for the propagation of adenoviral vectors with genetically modified receptor specificities , 1999, Nature Biotechnology.

[16]  C. Miller,et al.  An Adenovirus Vector with Genetically Modified Fibers Demonstrates Expanded Tropism via Utilization of a Coxsackievirus and Adenovirus Receptor-Independent Cell Entry Mechanism , 1998, Journal of Virology.

[17]  G. Zeng.  Sticky-end PCR: new method for subcloning. , 1998, BioTechniques.

[18]  C. Miller,et al.  Characterization of an Adenovirus Vector Containing a Heterologous Peptide Epitope in the HI Loop of the Fiber Knob , 1998, Journal of Virology.

[19]  D. Brough,et al.  Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins , 1997, Journal of virology.

[20]  J. Bergelson,et al.  Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.

[21]  J. Engler,et al.  Domains required for assembly of adenovirus type 2 fiber trimers , 1996, Journal of virology.

[22]  D. Curiel,et al.  Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism , 1996, Journal of virology.

[23]  M. Mehtali,et al.  Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli , 1996, Journal of virology.

[24]  D. Curiel,et al.  Addition of a short peptide ligand to the adenovirus fiber protein. , 1995, Gene therapy.

[25]  G. Nemerow,et al.  Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization , 1994, The Journal of cell biology.

[26]  R. Crystal,et al.  Adenovirus‐Mediated in Vivo Gene Transfer , 1994, Annals of the New York Academy of Sciences.

[27]  G. Nemerow,et al.  Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment , 1993, Cell.

[28]  C. O’Riordan,et al.  Strategies to adapt adenoviral vectors for targeted delivery. , 2003, Methods in molecular medicine.

[29]  D. Curiel,et al.  Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  R. Alemany,et al.  A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.